Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura van Vliet

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Neuromuscular Diseases|November 18, 2016
Accurate Dystrophin Quantification in Mouse Tissue; Identification of New and Evaluation of Existing MethodsMargriet Hulsker, Ingrid Verhaart, Laura van Vliet, et al.
Plos Currents|July 22, 2014
Generation of embryonic stem cells and mice for duchenne researchMarcel Veltrop, Jos van der Kaa, Jill Claassens, et al.
Molecular Genetics and Metabolism|November 11, 2006
Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type IIToshika Okumiya, Marian A Kroos, Laura Van Vliet, et al.
BMC Medical Genetics|December 3, 2008
Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophyLaura van Vliet, Christa L de Winter, Judith C T van Deutekom, et al.
Human Mutation|April 22, 2008
Update of the Pompe disease mutation database with 107 sequence variants and a format for severity ratingMarian Kroos, Robert J Pomponio, Laura van Vliet, et al.
Plos One|March 31, 2018
Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophyBauke Kogelman, Artem Khmelinskii, Ingrid Verhaart, et al.
Molecular Genetics and Metabolism|July 15, 2023
Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiencyEline C B Eskes, Martijn J C van der Lienden, Barbara Sjouke, et al.
Plos One|February 22, 2018
A dystrophic Duchenne mouse model for testing human antisense oligonucleotidesMarcel Veltrop, Laura van Vliet, Margriet Hulsker, et al.
European Journal of Human Genetics : EJHG|February 28, 2008
p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?Marian A Kroos, Reinier A Mullaart, Laura Van Vliet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2008
Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanismsAnnemieke Aartsma-Rus, Laura van Vliet, Marscha Hirschi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Neuromuscular Diseases|November 18, 2016
Accurate Dystrophin Quantification in Mouse Tissue; Identification of New and Evaluation of Existing MethodsMargriet Hulsker, Ingrid Verhaart, Laura van Vliet, et al.
Plos Currents|July 22, 2014
Generation of embryonic stem cells and mice for duchenne researchMarcel Veltrop, Jos van der Kaa, Jill Claassens, et al.
Molecular Genetics and Metabolism|November 11, 2006
Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type IIToshika Okumiya, Marian A Kroos, Laura Van Vliet, et al.
BMC Medical Genetics|December 3, 2008
Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophyLaura van Vliet, Christa L de Winter, Judith C T van Deutekom, et al.
Human Mutation|April 22, 2008
Update of the Pompe disease mutation database with 107 sequence variants and a format for severity ratingMarian Kroos, Robert J Pomponio, Laura van Vliet, et al.
Plos One|March 31, 2018
Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophyBauke Kogelman, Artem Khmelinskii, Ingrid Verhaart, et al.
Molecular Genetics and Metabolism|July 15, 2023
Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiencyEline C B Eskes, Martijn J C van der Lienden, Barbara Sjouke, et al.
Plos One|February 22, 2018
A dystrophic Duchenne mouse model for testing human antisense oligonucleotidesMarcel Veltrop, Laura van Vliet, Margriet Hulsker, et al.
European Journal of Human Genetics : EJHG|February 28, 2008
p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?Marian A Kroos, Reinier A Mullaart, Laura Van Vliet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2008
Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanismsAnnemieke Aartsma-Rus, Laura van Vliet, Marscha Hirschi, et al.
Pageof 2